This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Masaaki Kimura: Innovator in RXR-Antagonist Compounds
Introduction
Masaaki Kimura is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that exhibit RXR-antagonist efficacy. His work aims to address various health conditions associated with RXR-antagonism.
Latest Patents
Masaaki Kimura holds a patent for "11-phenyl-dibenzodiazepine derivatives as RXR-antagonists." This invention relates to benzodiazepine compounds that can delay the progression of, prevent, or treat conditions such as diabetes and its complications, including retinopathy, nephropathy, neuropathy, hyperlipidemia, obesity, dyslipidemia, and osteoporosis. He has 1 patent to his name.
Career Highlights
Masaaki Kimura is currently associated with Novartis AG, a leading global healthcare company. His role involves research and development of innovative therapeutic solutions that can improve patient outcomes.
Collaborations
Throughout his career, Masaaki has collaborated with esteemed colleagues, including Junichi Sakaki and Kazuhide Konishi. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Masaaki Kimura's work in RXR-antagonist compounds represents a significant advancement in the field of medicinal chemistry. His innovative approach to treating complex health conditions showcases the importance of research and collaboration in the pursuit of medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile